Tag | Content |
---|
EnhancerAtlas ID | HS023-23933 |
Organism | Homo sapiens |
Tissue/cell | CD8+ |
Coordinate | chr8:2093380-2095640 |
Target genes | |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
CREB3 | MA0638.1 | chr8:2094554-2094568 | CTGACACGTCACCA | + | 6.78 | ESRRB | MA0141.3 | chr8:2094272-2094283 | TTTGACCTTGA | - | 6.14 | IRF1 | MA0050.2 | chr8:2095577-2095598 | CTTTTCTTTCTTTTTTTTTTT | + | 6.41 | RORA | MA0071.1 | chr8:2094274-2094284 | TGACCTTGAT | - | 6.02 | TCF7L2 | MA0523.1 | chr8:2093863-2093877 | TCTCTTTGAACTTT | - | 6.08 |
|
| Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
SE_12283 | chr8:2092526-2095308 | CD3 | SE_20576 | chr8:2092461-2095726 | CD56 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 5 | Chromosome | Start | End |
chr8 | 2094001 | 2094164 | chr8 | 2094166 | 2094404 | chr8 | 2094462 | 2094719 | chr8 | 2094833 | 2095141 | chr8 | 2095185 | 2095235 |
|
| Number: 1 | ID | Chromosome | Start | End |
GH08I002144 | chr8 | 2092719 | 2095482 |
|
Enhancer Sequence | CCTTGTTGTG GTTTTCCTGT ACCAAATCAC ACCTACCTGC CCCTGCTCAC CCCCTGGCTT 60 GTTTAATTAT GGGTTATCAT GCACTTTCAC GGCTGGTGGG GTGCAGATAG TGCACTCACC 120 CTCCAGAGAG CAGGGCATGG TGAATCACAC CCCCAAAGCC CCTCCGACCC ACGGGGCTGG 180 GCTGCTGGCC CCCAGCGGCA CCCAAGACGG CACCAGTCCT AAGAAGTGTG CGTTTTGTGC 240 AAGGCTTAGA AAGGCCACCT AGTGATTATA CCACGGATCT AAAAGTCTCT GTAGAGGAAA 300 ATGAAATGCA AAGATGGCTC TGTTCTTTTT TAGTGTGCTA ATGAATTAGG AAGGGATTTC 360 AAAAGAAAGA AGGCACTCAT TCAGAATGAT CACTGCAGTA GCCATGGAGG AAAAATAAAA 420 ACTTGGCTGC CTACACAAGG CCTCTTGGTG AAGTTAAAAA ACGTGTTTAG GAGGAACATA 480 CCCTCTCTTT GAACTTTTTC CTCCTTTGTT TGGAAAGAGG CTGAAATTCT TCTGGCATAA 540 AAATCCCATT TCAATATTTT AGTTTTATTG TTGCTTTATA ACAGAAAAAG CTTTGATAAT 600 TAAGAATGTT TTACCTTTCT GTGTCATTAA GGGCAATCCA AATTTTACGA GAATTTGTTA 660 TATTTTTCTA AGGTAATAAT ACAAATCCTG AGAATTAAAT ATGTCCCCAG TAACATAAAG 720 CTGGCTGAGC TGGTTTCCAT GGCAGTAAAG TGAGTATCAG CAAGAATTTT ATTTTTGTTA 780 TTTCTCCCTT TTCTGTCGTG CAGATGAACT TGAGCGGAGT TTGTTCTTAT TGCGTGGTGG 840 CAGCCGCATT TTCCAAAGCG TGCTTGGCAA GGGTAGGCGC AGACAGTCTC AGTTTGACCT 900 TGATTTAGTT AAACAGATTT TGTTTATTTT CCAGTTTAAA CAGTCATTTT TGTTTAGCAA 960 TCGTGGTTCA TGGGAAATAA TTCAAATGGT TGTGAATTTC TTGAAGCCAT ATATACTATT 1020 TTTAATAGAC CTCCTTTTTG AGCAGTTTTA GGTTCACAGC AAAGTTAAAA GGAAGGTAGA 1080 GATCTCCACT CCAACCCCTA CCCCCACCAC AGCTTCCCCC GCTACCAACA CCTCCCACCA 1140 GAGGGATGTG CTTGTTACAA CCGCTGCACC CACACTGACA CGTCACCATC CTCGCAGGCT 1200 GGAGTTTACC CTGGGCTCGC TTCTGGCGCT TGTTACAACT GCTGCACCCA CACTGAAGCG 1260 TCAGCATTGC CGGGGGCTGG AGTTTACCCT GGGCACACTC CTGGTGCTGT TGGCTCTGTG 1320 GGTTTGGTCG GGTGATCAGG ACTCAGGTCC ACCATTGTAG CATCATGCAC AGTCTTTTCT 1380 CTGCCCTAAA AATCTTCCCT TCAACCACTG AGCATTTTAC TGCCTCCATA GTTTTGAGTT 1440 ATAATATTTT TTAAAAGACT TTTTTTTTAA AAGAATGAAA TAGTCTTAGA CATGCAGTAA 1500 AGTGTCTTTA CAACGGCGCA GAGAGCCCAG TGGACTCCAC AGTCTTCCTG TTGTTCACGT 1560 CTCGCGTTGC TGTGGGGCGA GACGATGGCC TCACCTCCAG GTGGCCTTCA GACCTTGCTG 1620 GGTTCCCCCA ATGCCCTCTC TCTGTCCCAG GACCCATCGA GGACACCAGA TGAATTTGCT 1680 GTTCACGTCT CCCAGCCCCT CCGTCCTGCG ATGGTTTCTG TCTGTCCTTG CCTTTCATGA 1740 CCTTAGTGGC TTTGAGGAGT TTTGCTGGTT ATCTTGTAGG ATGTTCCCCA ATCCAGGTCC 1800 CCAGTCCAGG GAAGACGATC TTCGTGTGAT GAGACTGGGG ATGTGTGCTT TTGGGAAGAG 1860 GAGTCACGTG GGGTGCCCGA CATCCGCTAA CCTTCATCAC TTGCTCAGGT GATGTCTGCC 1920 TGCTGTCTCC CATGAAATGC CTGCTTTTTC CTCTTCTCCT TCTATTCCTT GGGAGCCTGT 1980 CTCAGCCCAG ACCACCCTCA AAGAAGCAAG AGCATGGAAT CACGTTCACC TCTTGGAGCA 2040 GGAGCATCTA CCTCTGTTAT GTGCAATTCT TCTGGAAGAA AGATTGTCTC CTCTCCCTAT 2100 TTATTTATTT ATCCCATCAT TTACTGACAT CTGTATGGAC TCTTGTGCTG TATTTCAGCT 2160 CTGGGATGTG ACCCATGTTT CGCCATGCAT TTTCTTTCTT TTCTTTCTTT TTTTTTTTTT 2220 TTGAGACACA GTCTCCCTTT GTTGCTCAGG CTGGAGTGCA 2260
|